Queensland pharmacists may be aware of the recent announcement from Queensland Health offering community pharmacists and community pharmacy owners the opportunity to make an expression
Pharmacists practising in Queensland are advised the UTIPP-Q pilot has finished and the Urinary Tract Infection Community Pharmacy Service is now allowed under the Pharmacists
Pharmacists practising in Queensland are advised that after Friday, 9 September 2022, new pharmacists and pharmacies will no longer be accepted into the UTIPP-Q pilot.
PDL is pleased to provide further information to pharmacists practising in Queensland about the UTIPP-Q pilot program and recent announcements. The following advice is directed
Pharmacists practising in Queensland are advised the UTIPP-Q pilot program has been extended. The following message to participating pharmacists from the Consortium managing the pilot
PDL has previously informed members likely to be working in Queensland of the mandatory requirements of the QScript real-time prescription monitoring system. The practice alerts
Pharmacists practising in Queensland are advised the UTIPP-Q pilot program has been extended. The following message to participating pharmacists from the Consortium managing the pilot
As pharmacists working in Queensland should be aware, integration of the QScript system into practice became mandated on Thursday, 28 October 2021. Legal and professional responsibility It
Queensland Health has released information about the Queensland real time prescription monitoring system, QScript, in anticipation of its introduction later this year. As the recognised
Pharmacists may be aware of the Urinary Tract Infection Pharmacy Pilot – Queensland (UTIPP-Q) program. The UTIPP-Q program is a research pilot program to investigate
Pharmaceutical Defence Limited (PDL) acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, waters and community. We pay our respects to the people, the cultures and the Elders past and present.